{"database": "openregs", "table": "documents", "rows": [["FDA-2014-N-0002-0081", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-276 ZILMAX plus RUMENSIN plus TYLAN (zilpaterol hydrochloride 4.8%; monensin, USP; and tylosin phosphate) Type A Medicated Articles For Use in the Manufacture of Type B and C Medicated Feeds Cattle Fed in Confinement for Slaughter re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:57Z", null, 0, 0, "0900006481a45f5c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-N-0002-0081"], "units": {}, "query_ms": 5.306096994900145, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}